EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89

Janhavi Venkataraman iD, Kefah Mokbel

Current Oncology · 17.04.2026 · 33 (4) · 223

DOI: 10.3390/curroncol33040223 ↗

Kurz gefasst

Kommentar in der Zeitschrift Current Oncology, online erschienen am 17.04.2026. Verfasst von Janhavi Venkataraman und 1 weiteren Autor:innen. Beteiligte Einrichtung: The London Breast Institute, Princess Grace Hospital, HCA Healthcare Private Limited, London W1U 5NY, UK. Hauptthemen laut MEDLINE: Breast Neoplasms, Mastectomy, Tamoxifen, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sae-sim et al [...]

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMastectomyTamoxifenNeoplasm Recurrence, LocalCarcinoma, Intraductal, NoninfiltratingAntineoplastic Agents, HormonalHumansFemaleDisease-Free Survival

Substanzen

TamoxifenAntineoplastic Agents, Hormonal

Autor:innen und Institutionen

  • The London Breast Institute, Princess Grace Hospital, HCA Healthcare Private Limited, London W1U 5NY, UK.

ORCID-Profile: Janhavi Venkataraman

Zitieren

APA

Venkataraman, J., & Mokbel, K. (2026). Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89. Current Oncology, 33(4), 223. https://doi.org/10.3390/curroncol33040223

Vancouver

Venkataraman J, Mokbel K. Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89. Current Oncology. 2026;33(4):223. doi:10.3390/curroncol33040223

BibTeX
@article{Venkataraman2026,
  author = {Venkataraman, Janhavi and Mokbel, Kefah},
  title = {Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {4},
  pages = {223},
  doi = {10.3390/curroncol33040223}
}
Kostenlos starten →